Structural Biology

T.R. Sosnick, L. Mayne, R. Hiller, S.W. Englander, "The barriers in protein folding," Nature Structural Biology 1:149-156, 1994. (Cited in approximately 40 publications through July 1995) Comments by S. Walter Englander, University of Pennsylvania Medical Center "The protein folding problem--the way in which unfolded proteins manage to reach their native, three-dimensional, functional form--has become a central focus for many scientists," declares Walter Englander, a professor of biochemistry a

Written byNeeraja Sankaran
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Comments by S. Walter Englander, University of Pennsylvania Medical Center

"The protein folding problem--the way in which unfolded proteins manage to reach their native, three-dimensional, functional form--has become a central focus for many scientists," declares Walter Englander, a professor of biochemistry and biophysics at the University of Pennsylvania Medical Center. For instance, he elaborates, "protein chemists care about it for pure science; cell biologists are interested in it with respect to cell stress proteins called chaperones; and it is a big-money issue for the protein designers and pharmacological chemists who want to clone proteins in unusual environments or design new proteins.

SLOW TRACK, FAST TRACK: From left, Tobin Sosnick, Wlater Englander, and Leland Mayne have proposed that the rate-limiting step in protein folding comes from the structural reorganization of the misfolded molecules.

Previously, Englander recounts, "it had been thought that the rate-limiting step occurs late in the folding process and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies